SPOTLIGHT -
Sustainability Sea Change: The Top 5 ESG Challenges for Pharma
Outlining the most important sustainability-related hurdles facing leading biopharma companies today—and current efforts underway to meet new expectations in advancing this strategic mandate.
Why ESG Performance Metrics Matter
Meaningful biopharma sustainability metrics are a crucial challenge.
A New Year for Sustainable Governance
Biopharma sustainability resolutions for a better 2021.
Biopharma Joins Race to Net-Zero Carbon Emissions
Why major companies are stepping up environmental commitments.
Synthetic Biology and the Environment
SynBio opens new environmental sustainability possibilities for pharma.
The Regulatory Engagement Conundrum
Biopharma must find sustainable models for public policy engagement.
Sustainable Long-Term Planning
ESG objectives are integral to long-term biopharma strategy.
Pharma’s Digital-Trust Mandate
The need for clear transparency around use of real-world data, AI.